Protective effect of Sam-Hwang-Sa-Sim-Tang against hepatic steatosis in mice fed a high-cholesterol diet
| Autor: | Joo-Young Lee, Tae-Gue Ahn, Se-Yun Cheon, Yoon-Bum Kook, Hyo-Jin An |
|---|---|
| Rok vydání: | 2013 |
| Předmět: |
Male
medicine.medical_specialty Liver steatsosis Normal diet Diet High-Fat Protective Agents High-cholesterol diet (HCD) Mice chemistry.chemical_compound Internal medicine Republic of Korea Hyperlipidemia medicine Animals Humans Liver X receptor Liver X Receptors Interleukin-6 Plant Extracts Tumor Necrosis Factor-alpha Cholesterol business.industry Fatty liver General Medicine Intercellular Adhesion Molecule-1 Orphan Nuclear Receptors medicine.disease Fatty Liver Mice Inbred C57BL Endocrinology Complementary and alternative medicine chemistry LDL receptor Sam-Hwang-Sa-Sim-Tang (SHSST) Acyl Coenzyme A Steatosis business Research Article Lipoprotein |
| Zdroj: | BMC Complementary and Alternative Medicine |
| ISSN: | 1472-6882 |
| Popis: | Background Sam-Hwang-Sa-Sim-Tang (SHSST) is a traditional Oriental medication that has been commonly used in Korea for the treatment of hypertension, insomnia, and chest pain. In addition, some studies reported that administration of SHSST results suppression of hyperlipidemia in rats or lowering lipid plasma level such as total cholesterol (TC). Those results made us find and demonstrate positive effect of SHSST much more. The aim of the current study was to examine whether SHSST exerts an effect against hepatic steatosis and two type of SHSST has different efficacy on liver steatosis. Methods Total 40 mice were divided randomly and equally into 4 groups: a normal diet (CON) group, high-cholesterol diet (HC) group, and treatment groups fed a high-cholesterol diet (HCD) with a 30% or 80% ethanol extract of SHSST (SHSST-L and SHSST-H, respectively). The HCD was given for 9 weeks. The SHSST-treated groups were orally administered SHSST at a dose of 150 mg/kg, whereas the other groups received physiological saline. Results SHSST administration to mice resulted in a decline in serum levels of total cholesterol and low-density lipoprotein. Histological examination showed that lipid droplets were smaller in the SHSST-treated group than in the HC group. At the protein level, expression of sterol regulatory element-binding protein 2 (SREBP-2) was suppressed by SHSST. In addition, the mRNA expression of cholesterol metabolism-related molecules such as SREBP-2, liver X receptor (LXR), low-density lipoprotein receptor (LDLR), and 3-hydroxy-3methylglutary-CoA (HMG-CoA) was also suppressed in SHSST-treated groups in the liver. In the aorta tissue, SHSST decreased the expression of tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1(VCAM-1), transforming growth factor (TGF)-β1, and fibronectin. Conclusions The present study indicates that SHSST protects against liver steatosis and protects vessels against inflammation arising from excessive ingestion of cholesterol. These findings may also suggest that SHSST could be used as an adjuvant remedy for protection against liver steatosis. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink